Antinociceptive effects of intrathecal cimifugin treatment: a preliminary rat study based on formalin test.

Anesth Pain Med (Seoul)

Department of Anesthesiology and Pain Medicine, School of Medicine, Chosun University, Gwangju, Korea.

Published: October 2020

AI Article Synopsis

  • Cimifugin, a component from a traditional analgesic root, was tested for pain relief in a study utilizing the formalin test on male rats.
  • The research involved administering varying doses of cimifugin and observing the rats' flinch responses in two phases after formalin injection.
  • Results showed significant pain reduction with specific doses of cimifugin in both phases, indicating its effectiveness as an antinociceptive agent at different concentrations.

Article Abstract

Background: Cimifugin is one of the components of the root of . The extract derived from is traditionally used as an analgesic. This study was conducted to evaluate the analgesic effect of intrathecal cimifugin in the formalin test.

Methods: Male Sprague-Dawley rats (n = 20) were randomized into four groups for intrathecal administration of 70% dimethylsulfoxide and various doses of cimifugin (100 μg, 300 μg, and 1,000 μg). The typical flinch response after the injection of 5% formalin into the hind paw was assessed in two distinct phases: phase 1 until 10 min, and phase 2 from 10 min to 60 min. ED values were calculated via linear regression.

Results: Intrathecal cimifugin significantly reduced the flinch response in both phases of the formalin test. Significant antinociceptive effects of cimifugin were found with the dose of 300 μg in phase 1 and the dose of 100 μg in phase 2. The ED value (95% confidence intervals) of intrathecal cimifugin was 696.1 (360.8-1,342.8) μg during phase 1 and 1,242.8 (42.0-48,292.5) μg during phase 2.

Conclusions: Intrathecal cimifugin has an antinociceptive effect against formalin-induced pain. Cimifugin has an anti-inflammatory effect at low concentrations, and non-inflammatory analgesic effect at higher concentrations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724115PMC
http://dx.doi.org/10.17085/apm.20032DOI Listing

Publication Analysis

Top Keywords

intrathecal cimifugin
20
μg phase
16
cimifugin
9
antinociceptive effects
8
formalin test
8
100 μg
8
300 μg
8
flinch response
8
phase min
8
μg
7

Similar Publications

Antinociceptive effects of intrathecal cimifugin treatment: a preliminary rat study based on formalin test.

Anesth Pain Med (Seoul)

October 2020

Department of Anesthesiology and Pain Medicine, School of Medicine, Chosun University, Gwangju, Korea.

Article Synopsis
  • Cimifugin, a component from a traditional analgesic root, was tested for pain relief in a study utilizing the formalin test on male rats.
  • The research involved administering varying doses of cimifugin and observing the rats' flinch responses in two phases after formalin injection.
  • Results showed significant pain reduction with specific doses of cimifugin in both phases, indicating its effectiveness as an antinociceptive agent at different concentrations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!